Skip to main content

Tibial Fractures

2
Pipeline Programs
7
Companies
9
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
2 programs
1
1
InductOsPhase 41 trial
CP-533, 536Phase 21 trial
Active Trials
NCT00533377Completed276Est. May 2010
NCT00161616Completed277Est. Aug 2008
Innovation Pharmaceuticals
2 programs
ETN with ASLSN/A1 trial
External fixatorN/A1 trial
Active Trials
NCT00875992Completed141Est. Dec 2012
NCT03166267Completed10Est. Feb 2021
iNova Pharmaceuticals
iNova PharmaceuticalsAustralia - Chatswood
1 program
3D printed plastic model prototypeN/A1 trial
Active Trials
NCT02845245Terminated20Est. Aug 2020
Biocomposites
BiocompositesChina - Shanghai
1 program
Calcium Sulfate + Antibiotics + Internal FixationN/A1 trial
Active Trials
NCT02456194Completed30Est. May 2021
Bioventus
BioventusDURHAM, NC
1 program
Exogen 4000+N/A1 trial
Active Trials
NCT00667849Terminated501Est. Dec 2012
Stryker
StrykerCA - San Jose
1 program
T2 Alpha Tibia Nailing SystemN/A1 trial
Active Trials
NCT04015167Completed103Est. Aug 2023
Zimmer Biomet
Zimmer BiometFL - Jacksonville
1 program
ZNN Bactiguard tibiaN/A1 trial
Active Trials
NCT05022485Recruiting500Est. Jul 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
PfizerInductOs
PfizerCP-533, 536
Zimmer BiometZNN Bactiguard tibia
StrykerT2 Alpha Tibia Nailing System
Innovation PharmaceuticalsExternal fixator
iNova Pharmaceuticals3D printed plastic model prototype
BiocompositesCalcium Sulfate + Antibiotics + Internal Fixation
Innovation PharmaceuticalsETN with ASLS
BioventusExogen 4000+

Clinical Trials (9)

Total enrollment: 1,858 patients across 9 trials

NCT00161616PfizerInductOs

Study Evaluating InductOs in Diaphyseal Tibia Fractures

Start: Sep 2003Est. completion: Aug 2008277 patients
Phase 4Completed
NCT00533377PfizerCP-533, 536

ACTiF- Assessment of Closed Tibial Fractures

Start: Jan 2008Est. completion: May 2010276 patients
Phase 2Completed
NCT05022485Zimmer BiometZNN Bactiguard tibia

Zimmer® Natural Nail® (ZNN) Bactiguard Tibia Post-Market Clinical Follow-up Study

Start: Apr 2022Est. completion: Jul 2027500 patients
N/ARecruiting
NCT04015167StrykerT2 Alpha Tibia Nailing System

A Post-Market Clinical Evaluation of the Treatment of Tibia Fractures With the T2 Alpha Tibia Nailing System

Start: Sep 2019Est. completion: Aug 2023103 patients
N/ACompleted
NCT03166267Innovation PharmaceuticalsExternal fixator

Real Life Weight Bearing After Tibial Fractures

Start: May 2018Est. completion: Feb 202110 patients
N/ACompleted
NCT02845245iNova Pharmaceuticals3D printed plastic model prototype

Comminuted Intra-Articular Distal Tibia Fracture Fixation Using Computer Techniques

Start: Sep 2016Est. completion: Aug 202020 patients
N/ATerminated
NCT02456194BiocompositesCalcium Sulfate + Antibiotics + Internal Fixation

Management of Traumatic Bone Defects in Tibial Plateau Fractures With Antibiotic-Impregnated Biodegradable Calcium Sulfate Beads: A Prospective Clinical Trial

Start: Sep 2015Est. completion: May 202130 patients
N/ACompleted
NCT00875992Innovation PharmaceuticalsETN with ASLS

Trial to Evaluate the Effectiveness of Angular Stable Locking System (ASLS) in Patients With Distal Tibial Fractures

Start: Jun 2009Est. completion: Dec 2012141 patients
N/ACompleted
NCT00667849BioventusExogen 4000+

Trial to Evaluate UltraSound in the Treatment of Tibial Fractures

Start: Sep 2008Est. completion: Dec 2012501 patients
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 1,858 patients
7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.